Litcius/Paper detail

Ketamine and Hydroxynorketamine as Novel Pharmacotherapies for the Treatment of Opioid Use Disorders

Onisiforou Anna, Andria Michael, Markos Apostolakis, Elmar Mammadov, Angeliki Mitka, Maria A Kalatta, Morfeas Koumas, Andrea Georgiou, Andreas Chatzittofis, Georgia Panayiotou, Polymnia Gergiou, Carlos A. Zarate, Panos Zanos

2024Biological Psychiatry13 citationsDOIOpen Access PDF

Topics & Concepts

KetamineMedicineAbstinenceOpioid use disorderOpioidPsychiatryDrugIntensive care medicineInternal medicineReceptorTreatment of Major DepressionTryptophan and brain disordersNeurotransmitter Receptor Influence on Behavior
Ketamine and Hydroxynorketamine as Novel Pharmacotherapies for the Treatment of Opioid Use Disorders | Litcius